Pharma Mar SA (PHMMF)
86.26
-0.10
(-0.12%)
USD |
OTCM |
Dec 10, 16:00
Pharma Mar EPS Diluted (Quarterly): -0.2748 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Grifols SA | 0.2183 |
| Oryzon Genomics SA | 0.0052 |
| Laboratorios Farmaceúticos Rovi SA | 1.326 |
| Almirall SA | -- |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.791M |
| Revenue (Quarterly) | 41.68M |
| Total Expenses (Quarterly) | 46.47M |
| Enterprise Value | 1.367B |
| Gross Profit Margin (Quarterly) | 87.90% |
| Profit Margin (Quarterly) | -11.50% |
| Earnings Yield | 2.47% |
| Operating Earnings Yield | 0.22% |
| Normalized Earnings Yield | 2.472 |